NCT02224768View on ClinicalTrials.gov

YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Advanced Melanoma
Interventions
DRUG

Ipilimumab

Trial Locations (2)

08540

Bristol-Myers Squibb, Princeton

PE27 5BZ

Local Institution, St Ives

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY